Skip to main content

Table 2 Differences in spirometry, lung volumes, and six-minute walk test

From: Functional recovery in a cohort of ECMO and non-ECMO acute respiratory distress syndrome survivors

 

Entire cohort

ECMO eligible cohort

ECMO (n = 34)

Non-ECMO (n = 76)

p value

ECMO (n = 34)

“ECMO Eligible” (n = 30)

P value

Primary outcome

FVC, % predicted

72 (56, 82)

70 (55, 82)

0.7

72 (56, 82)

70 (57, 78)

0.60

Secondary outcomes

FEV1, L

2.1 (1.8, 2.9)

2.1 (1.5, 2.6)

0.43

2.1 (1.8, 2.9)

2.3 (2.0, 2.9)

0.44

FEV1, % predicted

69 (58, 85)

67 (55, 80)

0.38

69 (58, 85)

70 (57–77)

0.60

FVC, L

2.7 (2.1, 3.4)

2.7 (2.1, 3.4)

0.76

2.7 (2.1, 3.4)

3.1 (2.5, 3.3)

0.46

FEV1/FVC%

84 (79, 87)

80 (76, 86)

0.18

84 (79, 87)

80 (76, 89)

0.67

TLC, L

4.4 (3.3, 5.4)

4.3 (3.4, 5.0)

0.73

4.4 (3.3, 5.4)

4.5 (3.6, 5.9)

0.47

TLC, % predicted

70 (58, 79)

70 (62, 85)

0.75

70 (58, 79)

61 (56, 83)

0.94

DLCO, % predicted

63 (48, 86)

64 (43, 79)

0.49

63 (48, 86)

62 (50, 75)

0.87

6MWT, m

367 (320, 444)

306 (234, 358)

0.12

367 (320, 444)

368 (325, 390)

0.84

  1. Data are presented as median (Q1,Q3) unless otherwise indicated